Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dexcel Pharma Ltd.

Division of Dexxon Ltd.
www.dexcelpharma.com

Latest From Dexcel Pharma Ltd.

Eisai Exits Dermatology Through Roivant Deal

Eisai has followed in the footsteps of Japanese peer Astellas by divesting assets in the dermatology area, this time through a deal with Roivant for a clinical stage atopic dermatitis therapy that it sees as no longer fitting into its strategic priorities.

BioPharmaceutical Japan

Zegerid OTC, Private Label Omeprazole Add Drug Interaction Warnings

CDER approves sNDAs from Bayer for Zegerid OTC powder and private label manufacturer Dexcel Pharma for omeprazole delayed release tablets to add label warnings on drug-drug interactions for methotrexate and mycophenolate mofetil.

Consumer BioPharmaceutical

Zegerid OTC, Private Label Omeprazole Add Drug Interaction Warnings

CDER approves sNDAs from Bayer for Zegerid OTC powder and private label manufacturer Dexcel Pharma for omeprazole delayed release tablets to add label warnings on drug-drug interactions for methotrexate and mycophenolate mofetil.

Consumer BioPharmaceutical

New CEO at Fair-Med

Baar, Switzerland-based Fair-Med has named Oren Weininger chief executive officer. Prior to joining the privately owned firm, which aims to provide patients with quality generic medicines at affordable prices, Mr Weininger worked at Dexcel Pharma. He said, "I hope as CEO I will bring the company to international success with a quick expansion, based on my experience." Fair-Med is currently present in Europe, Australian and the MENA region.

Switzerland
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Dexcel Ltd.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Middle East
      • Israel
  • Parent & Subsidiaries
  • Dexxon Ltd.
  • Senior Management
  • Dan Oren, Pres. & CEO
    Dov Avraham, VP, CFO
    Ilan Oren, VP, Bus. Dev.
    Ran Kreshtino, VP, Sales & Mktg., Israel
    Ygal Seelenfreund, VP, Sales & Mktg., Int'l
    Tomer Gold, VP, Clin. & Generic Dev.
  • Contact Info
  • Dexcel Pharma Ltd.
    Phone: (972) 4 6364000
    P.O. Box 50
    Or-Akiva, 30600
    Israel
Advertisement
Advertisement
UsernamePublicRestriction

Register